Kwality Pharmaceuticals has informed that it enclosed Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Updation on Bioequivalence (BE) Program- Successful Completion of Phase 1 by Kwality Pharmaceuticals.
The above information is a part of company’s filings submitted to BSE.